pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,142 catalysts · 5,811 phase readout · 2,325 8k filing · 346 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 16 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 11 catalysts2026-08-11: 7 catalysts2026-08-12: 13 catalysts2026-08-13: 11 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 1 catalyst2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 10 catalysts2026-10-29: 17 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,811
  • 8k filing2,325
  • earnings346
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT06140693: A Comparison of Affective Responses During Continuous and Interval Exercise

Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior

full page →ctgov ↗
›COMPLETEDphase readoutNCT06164106: Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide

Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395206: Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05902104: CGM-Assisted Management of PN

Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07580014: Choroidal and Retinal Features in PACD and POAG on OCT and OCTA

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Glaucoma, OCTA, Choroid

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02965716: Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT02738606: Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung, Recurrent Colorectal Carcinoma, Resectable Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT05193084: Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure

Sponsor: Heartfelt Technologies. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT07410533: Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: NA. Conditions: Pulsed Dye Laser, Rosacea

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07569133: Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease

Sponsor: Ho-Won Lee. Phase: NA. Conditions: Parkinson's Disease, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333781: Effects of Communication Training for Mental Health Occupational Therapy Interns

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Communication

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07364981: Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

Sponsor: Tel Aviv University. Phase: NA. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04712565: Hard and Soft Tissue Maintenance Around Implants With a Sloped Configuration

Sponsor: Medical University of Graz. Phase: NA. Conditions: Tooth Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT01047865: Type 1 Diabetes Recurrence in Pancreas Transplants

Sponsor: University of Miami. Phase: . Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT04864067: No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06613100: Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06934200: Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05935800: The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07638800: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05955300: Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis

Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609836: Caudal Dexamethasone - Bupivacaine in Neonates

Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

full page →ctgov ↗
›COMPLETEDphase readoutNCT03262636: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07349836: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583836: DELAYED VERSUS EARLY SURGICAL DECOMPRESSION FOR TRAUMATIC SPINAL CORD INJURY

Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07367971: Drug-Drug Interaction Study of ABP-671 in Gout Patients

Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380334: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06777134: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07568509: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07004699: Comparison of Two Ventilation Methods During Endoscopy of the Pharynx, Larynx and Oesophagus

Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05553132: A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects

Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07640932: Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung

full page →ctgov ↗
›COMPLETEDphase readoutNCT06216132: Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06438263: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06011187: Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Decision Support System, Outcome

full page →ctgov ↗
›COMPLETEDphase readoutNCT01073787: Intravenous Fluid for Pediatric Migraine in the Emergency Department

Sponsor: University of Alberta. Phase: PHASE1. Conditions: Migraine, Headache

full page →ctgov ↗
›COMPLETEDphase readoutNCT03575221: Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Osteogenesis Imperfecta, Short Stature

full page →ctgov ↗
›COMPLETEDphase readoutNCT07616193: Interaction Between Spasticity and the Initial Response After Balance Perturbations in Children With Spastic Cerebral Palsy

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Cerebral Palsy (CP), Typically Developing Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT06015893: Semaglutide Therapy for Alcohol Reduction (STAR)

Sponsor: National Institute on Drug Abuse (NIDA). Phase: PHASE2. Conditions: Addiction, Alcohol Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04936620: Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

Sponsor: St George's, University of London. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›RECRUITINGphase readoutNCT07092982: Comparison of Two Different Regional Anesthetic Methods in Total Knee Arthroplasty Patients

Sponsor: SB Istanbul Education and Research Hospital. Phase: NA. Conditions: Total Knee Arthroplasty, Ultrasound Guided Supra-inguinal Fascia Iliaca Block, Adductor Canal Block

full page →ctgov ↗
›RECRUITINGphase readoutNCT06630780: Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06104280: Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment

Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Opioid Use Disorder, Sleep Disturbance

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07647380: TIS for Improving Cognitive Impairment in Schizophrenia

Sponsor: Central South University. Phase: NA. Conditions: Schizophrenia Disorder, Cognitive Impairments

full page →ctgov ↗
›COMPLETEDphase readoutNCT04443062: Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Sponsor: Radboud University Medical Center. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07477262: Health Effects of a Walking Program in a High-Quality Tourism Environment for Older Women

Sponsor: Yu-fan Li. Phase: NA. Conditions: Overweight , Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT01999062: Automated Breast Radiation Therapy Using an MR-Guided Process

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02866162: Screening for Genes in Patients With Congenital Neutropenia

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Congenital Neutropenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07443761: Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.

Sponsor: University Hospital, Antwerp. Phase: . Conditions: Benign Pancreas Tumor, Malignant Pancreatic Neoplasm

full page →ctgov ↗
›COMPLETEDphase readoutNCT07047261: Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis

Sponsor: University of Turin, Italy. Phase: NA. Conditions: Peri-implant Mucositis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06459986: The Duration of Spinal Anaesthesia - a Prospective, Observational Cohort Study

Sponsor: Nordsjaellands Hospital. Phase: . Conditions: Orthopedic Disorder

full page →ctgov ↗
← prev
page 106 of 163
next →